Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Double-blind, Parallel Controlled, and Superiority Clinical Trial to Evaluate the Effectiveness and Safety of Ingested, Space Occupying Hydrogel Capsules for Simple Obesity Treatment

NCT06530017 is registered in ClinicalTrials.gov with IMEIK Technology Development Co., Ltd. as lead sponsor.

NCT NCT06530017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06530017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Double-blind, Parallel Controlled, and Superiority Clinical Trial to Evaluate the Effectiveness and Safety of Ingested, Space Occupying Hydrogel Capsules for Simple Obesity Treatment
Lead sponsor
IMEIK Technology Development Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2024
Completion date
June 30, 2026
Enrollment
440 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

simple obesity